Découverte, Radio-Canada

Personalized health monitoring, Anytime, Anywhere
Anasens is developing a new portable device for recurrent testing, useful for illicit drug detection, therapeutic drug monitoring (TDM) and chronic disease management.
The need for lab testing at home or where it matters
Every day, thousands of people spend hours traveling and waiting for the routine blood tests required for the monitoring of their chronic disease. What if it was possible to avoid such troubles to obtain your test results? Even better, what if these results were shared in real-time with your healthcare team?

More than 70% of medical decisions rely on laboratory tests
Current home technologies
Anasens brings the robustness of centralized laboratories in the palm of your hand
Nanotechnology, artificial intelligence, and connectivity are poised to disrupt personal medical technologies. The ability to quickly measure molecules in the body (blood, saliva, urine) and share this information will create a medical and commercial revolution. Anasens increases accessibility to precision medicine by offering lab-quality testing that can be done when and where it matters.
A medical and commercial revolution
Benefits:
Works directly into a drop of saliva or blood in one minute
Electrochemical sensing is inexpensive
Precise concentration measurement without user interpretation
Can detect up to six molecules/markers simultaneously
Can detect almost any type of molecule/marker
A seasoned team combining industry expertise and technical rigor
Built around experienced talent capable of uncovering solutions where others see challenges. At Anasens, individual experience fuels collective intelligence to develop high-impact solutions.
Partners
Subvention Axelys, Gouvernement Québec
Les Années Lumières , Radio-Canada
DrugAsens™ Distribution
Université de Montréal